Detalhe da pesquisa
1.
Efficacy and Safety of Continued Treatment With Mirikizumab in a Phase 2 Trial of Patients With Ulcerative Colitis.
Clin Gastroenterol Hepatol
; 20(1): 105-115.e14, 2022 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-32950748
2.
Deconvolution of monocyte responses in inflammatory bowel disease reveals an IL-1 cytokine network that regulates IL-23 in genetic and acquired IL-10 resistance.
Gut
; 70(6): 1023-1036, 2021 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-33037057
3.
Efficacy and Safety of Mirikizumab in a Randomized Phase 2 Study of Patients With Ulcerative Colitis.
Gastroenterology
; 158(3): 537-549.e10, 2020 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-31493397
4.
Predictive biomarker modeling of pediatric atopic dermatitis severity based on longitudinal serum collection.
Clin Exp Immunol
; 2021 Nov 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-35020861
5.
Discrepant salivary gland response after radioiodine and MIBG therapies.
Q J Nucl Med Mol Imaging
; 61(3): 331-339, 2017 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-25566809
6.
Biodistribution and radiation dosimetry of 124I-mIBG in adult patients with neural crest tumours and extrapolation to paediatric models.
EJNMMI Phys
; 11(1): 3, 2024 Jan 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-38167953
7.
Efficacy and Safety of 124I-MIBG Dosimetry-Guided High-Activity 131I-MIBG Therapy of Advanced Pheochromocytoma or Neuroblastoma.
J Nucl Med
; 64(6): 885-891, 2023 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-36732054
8.
Mirikizumab Regulates Genes Involved in Ulcerative Colitis Disease Activity and Anti-TNF Resistance: Results From a Phase 2 Study.
Clin Transl Gastroenterol
; 14(7): e00578, 2023 07 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36881820
9.
The oral spleen tyrosine kinase inhibitor fostamatinib attenuates inflammation and atherogenesis in low-density lipoprotein receptor-deficient mice.
Arterioscler Thromb Vasc Biol
; 31(9): 1991-9, 2011 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-21700926
10.
Therapeutic targeting of Syk in autoimmune diabetes.
J Immunol
; 185(3): 1532-43, 2010 Aug 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-20601600
11.
Diagnostic Performance of 124I-Metaiodobenzylguanidine PET/CT in Patients with Pheochromocytoma.
J Nucl Med
; 63(6): 869-874, 2022 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-34556526
12.
Proteomic characterisations of ulcerative colitis endoscopic biopsies associate with clinically relevant histological measurements of disease severity.
J Clin Pathol
; 75(9): 636-642, 2022 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-34353876
13.
The production of [124I]iodine and [86Y]yttrium.
Eur J Nucl Med Mol Imaging
; 38 Suppl 1: S4-9, 2011 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-21484376
14.
The influence of saliva flow stimulation on the absorbed radiation dose to the salivary glands during radioiodine therapy of thyroid cancer using 124I PET(/CT) imaging.
Eur J Nucl Med Mol Imaging
; 37(12): 2298-306, 2010 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-20625723
15.
In vivo biodistribution of calcium phosphate nanoparticles after intravascular, intramuscular, intratumoral, and soft tissue administration in mice investigated by small animal PET/CT.
Acta Biomater
; 109: 244-253, 2020 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-32251787
16.
Microbiological and Clinical Outcomes of Treating Non-Mycobacterium Avium Complex Nontuberculous Mycobacterial Pulmonary Disease: A Systematic Review and Meta-Analysis.
Chest
; 152(1): 120-142, 2017 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-28461147
17.
124I PET Assessment of Response of Bone Metastases to Initial Radioiodine Treatment of Differentiated Thyroid Cancer.
J Nucl Med
; 57(10): 1499-1504, 2016 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-27199362
18.
The role of the inhibitors of interleukin-6 signal transduction SHP2 and SOCS3 for desensitization of interleukin-6 signalling.
Biochem J
; 378(Pt 2): 449-60, 2004 Mar 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-14611646
19.
Syk inhibitors as treatment for allergic rhinitis.
Pulm Pharmacol Ther
; 21(3): 461-7, 2008.
Artigo
em Inglês
| MEDLINE | ID: mdl-17669674
20.
IL-1 receptor accessory protein and ST2 comprise the IL-33 receptor complex.
J Immunol
; 179(4): 2551-5, 2007 Aug 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-17675517